This is an outdated version published on 2020-08-11. Read the most recent version.

Vol. 72 No. 1 (2019), ARTÍCULOS ORIGINALES

Vol. 72 No. 1 (2019)

GASTRIC BYPASS IMPACT ON PATIENTS WITH BMI > 35 KG/M2 AND TYPE 2 DIABETES MELLITUS

ARTÍCULOS ORIGINALES

Published 2020-08-11

Luis Level⁺⁻
Lilian Navarro⁺⁻
Carlos Espinoza⁺⁻
Silvia Piñango⁺⁻
Yubisay Avariano⁺⁻

Luis Level

Cirujano General y Bariátrico. Jefe del servicio de Cirugía I del Hospital Dr. Miguel Pérez Carreño, Caracas – Venezuela. Director del curso de Postgrado de Cirugía General de la Universidad Central de Venezuela.

Lilian Navarro

Cirujano General. Adjunto del servicio de Cirugía del Hospital Uyapar, Puerto Ordaz – Estado Bolívar.

Carlos Espinoza

Cirujano General. Adjunto del servicio de Cirugía III del Hospital Dr. Miguel Pérez Carreño, Caracas – Venezuela.

Silvia Piñango

Cirujano General. Adjunto del servicio de Cirugía I y Coordinadora del curso de Postgrado de Cirugía General de la Universidad Central de Venezuela del Hospital Dr. Miguel Pérez Carreño, Caracas – Venezuela

Yubisay Avariano

Cirujano General. Adjunto del servicio de Cirugía I del Hospital Dr. Miguel Pérez Carreño, Caracas – Venezuela

Versions

2020-10-19 (2)
2020-08-11 (1)

HTML (Español (España))

PDF (Español (España))

Keywords

Cirugía bariátrica
Bypass gástrico laparoscópico
IMC ≥ 35 kg/m2
Diabetes mellitus tipo 2
Programa de cirugía bariátrica Bariatric surgery
Laparoscopic gastric bypass
BMI ≥ 35 kg/2
Type 2 diabetes mellitus
Bariatric surgery program

How to Cite

Level, L. ., Navarro, L. ., Espinoza, C. ., Piñango, S., & Avariano, Y. . (2020). GASTRIC BYPASS IMPACT ON PATIENTS WITH BMI > 35 KG/M2 AND TYPE 2 DIABETES MELLITUS. REVISTA VENEZOLANA DE CIRUGÍA, 72(1), 10–15. Retrieved from https://revistavenezolanadecirugia.com/index.php/revista/article/view/284

Abstract

Bariatric surgery has demonstrated that, besides producing significant and sustained weight loss, it can in most cases improve glycemic control and even produce diabetes remission in some patients. Objective: To analyze the effects of Roux-en-Y gastric bypass (RYGBP) in patients with BMI > 35 kg/m2 and type 2 diabetes operated in the bariatric surgery program of Dr. Miguel Pérez Carreño Hospital. Method: The investigation was descriptive, longitudinal and retrospective. The sample consisted of 20 patients attending the bariatric surgery program and underwent laparoscopic Roux-en-Y gastric bypass between 2011 and 015, with diagnosis of type 2 diabetes (T2DM). Results: After 1 year following RYGBP, significant decrease in glycaemia, glycosylated hemoglobin (HbA1c) and BMI was observed. Complete remission was observed in 75 % of patients, partial remission in 10 % and metabolic improvement in 15 %. Conclusions: RYGBP is effective in patients with T2DM, achieving a remission of 75% of treated patients

HTML (Español (España))

PDF (Español (España))